Compare CRMD & KTWO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | CRMD | KTWO |
|---|---|---|
| Founded | 2006 | 2025 |
| Country | United States | Cayman Islands |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 509.9M | 431.2M |
| IPO Year | 2009 | 2026 |
| Metric | CRMD | KTWO |
|---|---|---|
| Price | $6.61 | $9.87 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 6 | 0 |
| Target Price | ★ $14.67 | N/A |
| AVG Volume (30 Days) | ★ 1.4M | 99.2K |
| Earning Date | 03-05-2026 | N/A |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 780.00 | N/A |
| EPS | ★ 2.04 | N/A |
| Revenue | ★ $311,709,000.00 | N/A |
| Revenue This Year | $0.30 | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $3.17 | ★ N/A |
| Revenue Growth | ★ 617.03 | N/A |
| 52 Week Low | $5.60 | $9.84 |
| 52 Week High | $17.43 | $9.89 |
| Indicator | CRMD | KTWO |
|---|---|---|
| Relative Strength Index (RSI) | 43.67 | 49.71 |
| Support Level | $6.55 | N/A |
| Resistance Level | $7.44 | $9.89 |
| Average True Range (ATR) | 0.24 | 0.01 |
| MACD | 0.05 | -0.00 |
| Stochastic Oscillator | 58.83 | 60.00 |
Cormedix Inc is a biopharmaceutical company focused on developing and commercializing therapeutic products for life-threatening diseases and conditions. The Company's focus is on the commercialization of its product, DefenCath, in the United States and other key markets. The group currently operates in a single segment, Drug Product, located in a single geographic location, the United States.